Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Update on hairy cell leukemiaRobert J Kreitman, Evgeny AronsLeukemia & Lymphoma|May 24, 2011
Molecular variant of hairy cell leukemia with poor prognosisEvgeny Arons, Robert J KreitmanBlood Reviews|September 18, 2021
Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continuesRobert J Kreitman, Evgeny AronsBritish Journal of Haematology|May 10, 2006
Somatic hypermutation and VH gene usage in hairy cell leukaemiaEvgeny Arons, Joel Sunshine, Tara Suntum, et al.Blood|September 12, 2009
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapyEvgeny Arons, Tara Suntum, Maryalice Stetler-Stevenson, et al.British Journal of Haematology|June 17, 2014
Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndromeEvgeny Arons, Sharon Adams, David J Venzon, et al.British Journal of Haematology|April 5, 2014
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approachMariela Sivina, Robert J Kreitman, Evgeny Arons, et al.Leukemia Research|April 28, 2007
Immunoglobulin light chain repertoire in hairy cell leukemiaEvgeny Arons, Tara Suntum, Joel Sunshine, et al.Leukemia Research|February 26, 2008
PRAME expression in hairy cell leukemiaEvgeny Arons, Tara Suntum, Inger Margulies, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Bendamustine and rituximab in relapsed and refractory hairy cell leukemiaMauricio Burotto, Maryalice Stetler-Stevenson, Evgeny Arons, et al.Pageof 4